enGene Holdings Inc.
ENGN
$8.65
-$0.17-1.87%
NASDAQ
| 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 41.50% | -7.24% | 29.29% | 29.57% | 121.99% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 78.69% | 56.70% | 147.03% | 67.16% | 168.23% |
| Operating Income | -78.69% | -56.70% | -147.03% | -67.16% | -168.23% |
| Income Before Tax | -102.81% | -70.92% | -129.01% | 81.47% | -200.36% |
| Income Tax Expenses | 924.14% | 1,042.86% | 160.00% | 11.76% | -- |
| Earnings from Continuing Operations | -104.91% | -72.28% | -129.82% | 81.46% | -199.75% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -104.91% | -72.28% | -129.82% | 81.46% | -199.75% |
| EBIT | -78.69% | -56.70% | -147.03% | -67.16% | -168.23% |
| EBITDA | -78.79% | -56.79% | -147.93% | -67.73% | -168.77% |
| EPS Basic | -77.15% | -33.19% | -4.59% | 99.71% | 96.25% |
| Normalized Basic EPS | -75.32% | -32.14% | -7.91% | 99.07% | 87.35% |
| EPS Diluted | -77.15% | -33.19% | -4.59% | 99.71% | 96.25% |
| Normalized Diluted EPS | -75.32% | -32.14% | -7.91% | 99.07% | 87.35% |
| Average Basic Shares Outstanding | 15.69% | 29.35% | 119.75% | 6,168.18% | 6,198.16% |
| Average Diluted Shares Outstanding | 15.69% | 29.35% | 119.75% | 6,168.18% | 6,198.16% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |